News Digging > News > Incannex Launches Trial of IHL-675A for Rheumatoid Arthritis
Incannex Launches Trial of IHL-675A for Rheumatoid Arthritis
Incannex Launches Trial of IHL-675A for Rheumatoid Arthritis,Medicinal cannabinoid and psychedelic medicine company Incannex Healthcare (ASX:IHL) has commenced a Phase 2 clinical trial to assess the safety and

Incannex Launches Trial of IHL-675A for Rheumatoid Arthritis

Medicinal cannabinoid and psychedelic medicine company Incannex Healthcare (ASX:IHL) has commenced a Phase 2 clinical trial to assess the safety and